Survivor Winner Ethan Zohn Out of Remission

Ethan Zohn, the 2002 winner of Survivor: Africa, was diagnosed in May with stage II CD-20 positive Hodgkin's lymphoma, a rare, but treatable, form of the blood cancer. The soccer commentator, motivational speaker, and co-founder of the charity, Grassroot Soccer,

In late August, after giving the Survivor: Africa winner three months of intense chemotherapy, Zohn’s doctors discovered that the Hodgkin’s lymphoma Zohn had been fighting since spring had spread. "I have never been so scared in my life, for my life," the 35 year-old soccer commentator told PEOPLE Magazine in an exclusive interview.

He began new rounds of chemo in September, and underwent weeks of radiation therapy before his stem cell harvest two weeks ago. The stem-cell transplant will require a hospital stay of a full month, as doctors attempt to re-build Zohn’s red and white blood cell count from scratch – and render him cancer-free.
To follow his story, check out his website at http://www.ezohn.com/. To see his video diaries at people.com, go to: http://www.people.com/people/article/0,,20314739,00.html

His girlfriend, fellow Survivor alumni Jenna Morasca, has been chronicling her own thoughts about cancer as well. Most recently, she posted a break-up letter to cancer, saying, “In fact I am hoping by taking you out of my life and filling that spot with positive things that it may actually kill you. Gosh I can’t believe I am saying that I want you to die, BUT I DO! There I said it. I got it out of my system and into the universe. I do believe in karma and you will get yours. But it won’t be from me because I will be to busy living a happy joyous life to even think about revenge.

That’s all I need to say to you. Its over, goodbye, and see you NEVER AGAIN! Do not try and come back into my life because I will not change my mind. Its over.”

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap